SCHEMBL820846

SCHEMBL820846

CCCOC(=O)C(C(=O)OCCC)C(c1ccccc1)C1CCc2ccccc2C1=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.42
PTGS2 P35354 1/20 0.42
KDM4E B2RXH2 2/20 0.41
CYP19A1 P11511 2/20 0.39
TSHR P16473 2/20 0.37
LMNA P02545 2/20 0.37
CYP3A4 P08684 2/20 0.37
CHRM2 P08172 1/20 0.37
HTR1A P08908 1/20 0.37
ADRA2A P08913 1/20 0.37
CHRM1 P11229 1/20 0.37
DRD1 P21728 1/20 0.37
SLC6A2 P23975 1/20 0.37
ADRA1A P35348 1/20 0.37
OPRM1 P35372 1/20 0.37
DRD3 P35462 1/20 0.37
SLC6A3 Q01959 1/20 0.37
KCNH2 Q12809 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2D6 P10635 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL820213 1.00 ACHE (0.42) ACHEPTGS2KDM4ECYP19A1TSHR
SCHEMBL2139852 0.82 KDM4E (0.49) ACHEPTGS2KDM4ECYP19A1TSHR
SCHEMBL10450126 0.73 KDM4E (0.45) ACHEPTGS2KDM4ECYP19A1HTR1A
SCHEMBL10448555 0.73 KDM4E (0.45) ACHEPTGS2KDM4ECYP19A1HTR1A
SCHEMBL9345561 0.72 KDM4E (0.49) ACHEPTGS2KDM4ECYP19A1HTR1A
SCHEMBL8878719 0.72 KDM4E (0.40) ACHEPTGS2KDM4ECYP19A1
SCHEMBL15294423 0.71 KDM4E (0.64) ACHEKDM4ECYP19A1TSHRHTR1A
SCHEMBL2475301 0.71 KDM4E (0.45) ACHEPTGS2KDM4ECYP19A1TSHR
SCHEMBL9348192 0.70 KDM4E (0.52) ACHEKDM4ECYP19A1TSHRHTR1A
SCHEMBL15266500 0.69 KDM4E (0.41) ACHEPTGS2KDM4ECYP19A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8222177-B2 Catalyst and reaction process JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2012-07-17 US disclosed
US-20110054190-A1 CATALYST AND REACTION PROCESS JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2011-03-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110054190-A1 CATALYST AND REACTION PROCESS ME1, MAL2, ME2 ACHE 743/4885PTGS2 833/4885KDM4E 2954/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.